Results 161 to 170 of about 2,667 (184)

A Brief Review of Urate Transporter 1 (URAT1) Inhibitors for the Treatment of Hyperuricemia and Gout: Current Therapeutic Options and Potential Applications

European Journal of Pharmacology, 2021
Xu Zhao, Danni Song
exaly  

URAT1

2022
openaire   +1 more source

Discovery of Novel Verinurad Analogs as Dual Inhibitors of URAT1 and GLUT9 With Improved Druggability for the Treatment of Hyperuricemia

European Journal of Medicinal Chemistry, 2022
Jianjun Chen, Zean Zhao, Jianxin Pang
exaly  

URAT1

2021
openaire   +1 more source

CDER167, A Dual Inhibitor of URAT1 and GLUT9, Is a Novel and Potent Uricosuric Candidate for the Treatment of Hyperuricemia

Acta Pharmacologica Sinica, 2022
Jia-Yin Guo, YuanXin Tian, Lu Li
exaly  

Novel Urate Transporter 1 (URAT1) Inhibitors: A Review of Recent Patent Literature (2020–Present)

Expert Opinion on Therapeutic Patents, 2022
Xinyong Liu, Peng Zhan
exaly  

Apigenin Ameliorates Hyperuricemic Nephropathy by Inhibiting URAT1 and GLUT9 and Relieving Renal Fibrosis via the Wnt/β-Catenin Pathway

Phytomedicine, 2021
Zean Zhao, Jianxin Pang, Pingzheng Zhou
exaly  

INHIBITORS OF URAT1 AND PHARMACEUTICAL USES THEREOF

2022
WU TOM YAO-HSIANG, JIN QIHUI
openaire   +1 more source

Pharmacological Evaluation of a Novel Skeleton Compound Isobavachin (4′,7-Dihydroxy-8-Prenylflavanone) as a Hypouricemic Agent: Dual Actions of URAT1/GLUT9 and Xanthine Oxidase Inhibitory Activity

Bioorganic Chemistry, 2023
Fengxin Zheng, Kunlu Zhao, Hui Liao
exaly  

Novel selective URAT1 inhibitor shows promise in gout

Medicom Conference Report ACR 2023, 2023
openaire   +1 more source